Filing Flows

Filing Flows › Thermo Fisher Scientific (TMO) › Q1 2026

Thermo Fisher Scientific (TMO) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 1, 2026

Thermo Fisher Scientific (TMO) reported revenue of $11.0B for the first quarter 2026 (Q1 2026), +6% from a year earlier and -10% from the quarter before. Operating margin was 16.9%, net earnings $1.7B (15.0% of revenue).

Revenue$11.0B
Year over year+6%
Quarter over quarter-10%
Operating margin16.9%
Net earnings$1.7B

Thermo Fisher Scientific, Q1 2026: revenue $11.0B (+6% year over year), operating margin 16.9%, net earnings $1.7B, operating cash flow $1.2B. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$11.0B-10%+6%
Operating profit$1.9B-17%+9%
Net earnings$1.7B-16%+10%
Operating cash flow$1.2B-66%+65%
Free cash flow$816M-73%+126%

What changed

Revenue was $11.0B in Q1 2026, up 6% year over year and down 10% from the previous quarter. Laboratory Products and Biopharma Services was the largest line at 54% of revenue. Laboratory Products and Biopharma Services added $0.39B year over year (up 7%), 61% of the total change. Analytical Instruments declined 1%.

Operating profit was $1.9B, a 16.9% margin (up 0.4 points year over year). Of the extra revenue versus Q1 2025, 23% reached operating profit, above the 17% margin then. Total costs grew 6% against revenue growth of 6%. Net earnings were $1.7B, up 10% year over year. The effective tax rate was 4.1%.

Operating cash flow was $1.2B (up 65% year over year), 72% of net earnings. Non-cash charges added back $0.74B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $1.3B. Capital expenditures of $0.38B left free cash flow of $0.82B.

Questions

What was Thermo Fisher Scientific's revenue in the first quarter 2026?

Thermo Fisher Scientific (TMO) reported revenue of $11.0B for the first quarter 2026 (Q1 2026), +6% from a year earlier and -10% from the quarter before.

Was Thermo Fisher Scientific profitable in the first quarter 2026?

Operating profit was $1.9B (16.9% of revenue) and net earnings $1.7B.

Open the interactive Sankey →

Source: Thermo Fisher Scientific 10-Q on SEC EDGAR.